Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA GSK PHARMA CIPLA/
GSK PHARMA
 
P/E (TTM) x 33.7 57.2 58.9% View Chart
P/BV x 4.3 8.4 50.6% View Chart
Dividend Yield % 0.5 6.8 6.7%  

Financials

 CIPLA   GSK PHARMA
EQUITY SHARE DATA
    CIPLA
Mar-22
GSK PHARMA
Mar-22
CIPLA/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0831,917 56.5%   
Low Rs8061,400 57.6%   
Sales per share (Unadj.) Rs269.7193.5 139.4%  
Earnings per share (Unadj.) Rs31.722.5 141.1%  
Cash flow per share (Unadj.) Rs44.826.5 168.9%  
Dividends per share (Unadj.) Rs5.0090.00 5.6%  
Avg Dividend yield %0.55.4 9.8%  
Book value per share (Unadj.) Rs257.8157.2 164.0%  
Shares outstanding (eoy) m806.81169.41 476.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.58.6 40.9%   
Avg P/E ratio x29.873.8 40.4%  
P/CF ratio (eoy) x21.162.6 33.7%  
Price / Book Value ratio x3.710.6 34.7%  
Dividend payout %15.8400.4 3.9%   
Avg Mkt Cap Rs m762,177280,960 271.3%   
No. of employees `000NANA-   
Total wages/salary Rs m35,2996,102 578.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m217,63332,780 663.9%  
Other income Rs m3,217758 424.6%   
Total revenues Rs m220,85133,538 658.5%   
Gross profit Rs m43,2987,735 559.8%  
Depreciation Rs m10,520682 1,542.8%   
Interest Rs m1,06420 5,328.2%   
Profit before tax Rs m34,9337,790 448.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,3383,983 234.5%   
Profit after tax Rs m25,5953,808 672.2%  
Gross profit margin %19.923.6 84.3%  
Effective tax rate %26.751.1 52.3%   
Net profit margin %11.811.6 101.2%  
BALANCE SHEET DATA
Current assets Rs m147,10837,080 396.7%   
Current liabilities Rs m49,12916,984 289.3%   
Net working cap to sales %45.061.3 73.4%  
Current ratio x3.02.2 137.2%  
Inventory Days Days6391 69.0%  
Debtors Days Days6229 2.5%  
Net fixed assets Rs m119,4158,121 1,470.4%   
Share capital Rs m1,6141,694 95.3%   
"Free" reserves Rs m206,36424,936 827.6%   
Net worth Rs m207,97726,630 781.0%   
Long term debt Rs m4,1620-   
Total assets Rs m266,52345,201 589.6%  
Interest coverage x33.8391.3 8.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.7 112.6%   
Return on assets %10.08.5 118.1%  
Return on equity %12.314.3 86.1%  
Return on capital %17.029.3 57.9%  
Exports to sales %26.20-   
Imports to sales %8.227.0 30.3%   
Exports (fob) Rs m57,094NA-   
Imports (cif) Rs m17,8038,853 201.1%   
Fx inflow Rs m60,180528 11,402.4%   
Fx outflow Rs m17,8038,853 201.1%   
Net fx Rs m42,376-8,325 -509.0%   
CASH FLOW
From Operations Rs m33,2598,107 410.2%  
From Investments Rs m-18,719-4,055 461.6%  
From Financial Activity Rs m-15,998-5,242 305.2%  
Net Cashflow Rs m-1,323-1,190 111.2%  

Share Holding

Indian Promoters % 13.5 0.0 -  
Foreign collaborators % 20.1 75.0 26.8%  
Indian inst/Mut Fund % 49.4 12.7 388.4%  
FIIs % 27.7 2.2 1,275.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.4 25.0 265.6%  
Shareholders   388,864 116,651 333.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    


More on Cipla vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs GSK Pharma Share Price Performance

Period Cipla GSK Pharma S&P BSE HEALTHCARE
1-Day -0.35% -0.48% 0.23%
1-Month -4.65% -3.70% 0.36%
1-Year 14.22% -21.45% -6.87%
3-Year CAGR 33.00% -7.85% 20.16%
5-Year CAGR 12.52% -11.65% 11.07%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.6% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of 15.8%.

GSK Pharma paid Rs 90.0, and its dividend payout ratio stood at 400.4%.

You may visit here to review the dividend history of Cipla, and the dividend history of GSK Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Gains 211 Points | Tyre Stocks Rally while Metals Drag | 4 Reasons Why Indian Share Markets Hit Record High(Closing)

After opening the day lower mirroring weakness in Asian peers, Indian share markets staged a comeback and ended the trading session on an optimistic note.